Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$456K Sell
1,297
-27
-2% -$9.63K 0.13% 74
2025
Q4
$433K Sell
1,324
-38
-3% -$12.1K 0.12% 76
2025
Q3
$384K Sell
1,362
-8
-0.6% -$2.32K 0.11% 79
2025
Q2
$383K Sell
1,370
-15
-1% -$4.25K 0.11% 79
2025
Q1
$431K Buy
1,385
+54
+4% +$15.9K 0.14% 78
2024
Q4
$347K Sell
1,331
-124
-9% -$36.8K 0.11% 84
2024
Q3
$469K Sell
1,455
-5
-0.3% -$1.64K 0.14% 76
2024
Q2
$456K Sell
1,460
-134
-8% -$39.4K 0.14% 75
2024
Q1
$453K Sell
1,594
-56
-3% -$16.4K 0.15% 77
2023
Q4
$475K Sell
1,650
-107
-6% -$29.2K 0.18% 70
2023
Q3
$472K Sell
1,757
-51
-3% -$12.7K 0.19% 70
2023
Q2
$401K Sell
1,808
-23
-1% -$5.34K 0.15% 73
2023
Q1
$443K Sell
1,831
-9
-0.5% -$2.21K 0.18% 61
2022
Q4
$483K Sell
1,840
-8
-0.4% -$2.14K 0.21% 55
2022
Q3
$417K Sell
1,848
-43
-2% -$10.4K 0.2% 57
2022
Q2
$460K Buy
1,891
+3
+0.2% +$735 0.21% 59
2022
Q1
$457K Buy
1,888
+167
+10% +$38.4K 0.18% 68
2021
Q4
$387K Buy
1,721
+7
+0.4% +$1.48K 0.15% 75
2021
Q3
$364K Hold
1,714
0.15% 72
2021
Q2
$418K Hold
1,714
0.18% 58
2021
Q1
$426K Hold
1,714
0.2% 57
2020
Q4
$394K Sell
1,714
-131
-7% -$30.2K 0.2% 59
2020
Q3
$469K Hold
1,845
0.29% 44
2020
Q2
$435K Sell
1,845
-28
-1% -$6.39K 0.31% 47
2020
Q1
$380K Sell
1,873
-4
-0.2% -$874 0.36% 44
2019
Q4
$452K Buy
+1,877
New +$414K 0.33% 48

Other funds holding AMGN

Ballast Advisors's AMGN Position: Q1 2026 in Review

Ballast Advisors reduced its Amgen (AMGN) stake by 2% in Q1 2026, selling an estimated $9.63K and leaving 1,297 shares worth $456K. The position accounts for 0.13% of the portfolio, ranked #74.

Ballast Advisors first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $483K in Q4 2022. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ballast Advisors held 1,297 shares of Amgen worth $456K as of Q1 2026.
  • Ballast Advisors sold 27 Amgen shares in Q1 2026, an estimated $9.63K.
  • Amgen made up 0.13% of Ballast Advisors's portfolio in Q1 2026, its #74 holding.
  • Ballast Advisors first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • Ballast Advisors's Amgen position peaked at $483K in Q4 2022.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ballast Advisors's 13F filing for Q1 2026, filed 13 May 2026.